InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Rizvi Syed Ali-aamir, Directeur Médical. Director active across 1 companies, notably Caribou Biosciences, Inc.. Aggregated, 2 reports have been logged. The latest transaction was disclosed on 25 January 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
060,000 shares0
Common stock
SEC:0001209191-22-004860·
060,000 shares0
Common stock
SEC:0001209191-22-004860:0·
2 of 2 declarations
About Rizvi Syed Ali-aamir
Syed Ali-aamir Rizvi is the Chief Medical Officer at Caribou Biosciences, Inc. He is responsible for leading the company's medical and scientific initiatives. With expertise in biotechnology, Syed plays a key role in developing new treatments and therapies. His commitment to medical innovation is essential in ensuring that Caribou remains at the forefront of research and development.
